We evaluated whether immune activation (IA) and microbial translocation (MT) might play a role in accelerating liver disease progression in HIV-HBV/HCV co-infected patients.
Marchetti, G., Cozzi Lepri, A., Tincati, C., Calcagno, A., Ceccherini Silberstein, F., De Luca, A., Antinori, A., Castagna, A., Puoti, M., Monforte, A., Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study, <<BMC INFECTIOUS DISEASES>>, 2014; 14 (1): 79-79. [doi:10.1186/1471-2334-14-79] [http://hdl.handle.net/10807/54178]
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study
De Luca, Andrea;
2014
Abstract
We evaluated whether immune activation (IA) and microbial translocation (MT) might play a role in accelerating liver disease progression in HIV-HBV/HCV co-infected patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream-1411780253.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
516.74 kB
Formato
Adobe PDF
|
516.74 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
